NCT06885775View on ClinicalTrials.gov

Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

April 1, 2027

Study Completion Date

December 1, 2027

Conditions
Dermal FillersNasolabial Folds, Wrinkles
Interventions
DEVICE

DXP01

PCL Dermal Filler

DEVICE

Juvederm ULTRA 3

HA Dermal filler

Trial Locations (1)

10 Cozia Street, Building A,

Societatea Civila Medicala Dr. Rosu, Romania

All Listed Sponsors
lead

DEXLEVO

INDUSTRY